tomeko

Acute transverse myelitis with anti-MOG antibodies

Just diagnosed with Acute transverse myelitis with anti-MOG antibodies?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Acute transverse myelitis with anti-MOG antibodies, look for clinical trials, and connect with others living with it — all in one place.

Open the full Acute transverse myelitis with anti-MOG antibodies hub →

Overview

Acute transverse myelitis with anti-MOG antibodies is a rare condition. Also known as Acute transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies. Tomeko brings together the specialists, research, clinical trials, treatments and community for Acute transverse myelitis with anti-MOG antibodies so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:592873 · ICD-10 G37.3 · GARD 0022375

Find care for Acute transverse myelitis with anti-MOG antibodies

Authoritative references for Acute transverse myelitis with anti-MOG antibodies

Common questions

I was just diagnosed with Acute transverse myelitis with anti-MOG antibodies — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Acute transverse myelitis with anti-MOG antibodies, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Acute transverse myelitis with anti-MOG antibodies?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Acute transverse myelitis with anti-MOG antibodies, filtered to your area.

Are there clinical trials for Acute transverse myelitis with anti-MOG antibodies?

Tomeko shows live, recruiting studies for Acute transverse myelitis with anti-MOG antibodies from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com